Arkolith/Insider Trading/SCTX/Form 4

Parrot David

Chief Financial OfficerScribe Therapeutics, Inc. (SCTX) · full profile →Form 4 · filed Jul 28, 2026
Net Buying
Open-Market Buys
$40K
Open-Market Sells
$0
Net Open-Market Flow
$40K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 23, 2026Buy(P)1K$15.00$20K1K
Jul 23, 2026Buy(P)1K$15.00$20K1K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 23, 2026Grant(A)109K—$0109K
Jul 23, 2026Grant(A)109K—$0109K
Mar 13, 2026Grant(A)9K—$09K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002127908-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML